Today, the biotechnology market is driven by favorable government initiatives that are focused towards modernizing the drug regulatory pathway, standardizing clinical studies, improving reimbursement policies, and speeding up the product approval process, among others. These factors have been driving the market’s growth bandwagon. However, as critical as the biotech industry is, it is imperative for the players to maintain utmost quality standards, deliverability and be innovative.
Understanding this, Theertha Biopharma has been offering quality-oriented product design and cost effective development methodologies, with a focus on delivering affordable biosimilar therapeutics. Theertha was incorporated by the group of professionals in 2019 in Bangalore. A technically-adept team from diverse backgrounds has come together with vast experience in Product development, Quality, Regulatory and Business development; hence the very core thought process behind the inception of Theertha is to bring innovation in the product development and provide support services to other organizations who want to bring the potential difference in the field of Biopharmaceuticals.
Theertha Biopharma is an emerging biopharmaceutical company dedicated to the research, development, and commercialization of biosimilars and innovative molecules to transform the health standards of the global population through an effort to reduce therapeutic development costs and effectively accelerate
timelines while aiming to increase the possibility of success. Our team of experts has been on a constant mission to develop best-in-class biopharmaceuticals that optimize health outcomes and improve patients’ quality of life.
They are involved in robust pipeline growth, strong collaborations, and valuable partnerships with strategic partners to achieve the same. “We believe that Our platform technology with differentiated approach has the potential to reduce the expense and time associated with drug development in diseases with substantial unmet medical needs. Theertha with this approach support in the design & development of services to our customers, who are mostly seeking a high level of care and health services in addition to easing their challenges and making their lives better,” says Satish Babu Managing Director - Theertha Biopharma.
Perfect Partner for Pharma and Biotech Companies Globally
If we look at the company’s offerings, Theertha provides end to end support in Mammalian and Microbial biosimilar product development services using its robust platform technology resulting in high titre and recovery; the services include standard regulatory documentation package and support till clinical studies "It offers a varied range of cloning services for Microbial and mammalian nature with complete regulatory compliant data packages, gene synthesis and generation of expression plasmids, design construct and characterization," says Madhava Reddy Director Process and Technology
Theertha vision is to get ourselves established as a trusted and preferred partner in the biopharma space ensuring quality at affordable cost
The analytical capabilities of Theertha extended to evaluate, develop, qualify, and validate analytical methods of monograph based or in-house developed methods for evaluation of molecules effectively hand hold clients towards the end-objective. Theertha analytical experts are well versed in providing services with respect to method development using sophisticated and latest instruments/Equipments. Adding to it, Theertha also offers product characterization testing, deploying orthogonal approach Biopharmaceuticals/Pharmaceuticals products, according to Sathya Balan Director Analytical.
“We have phased out the development first to begin with biosimilars followed by in-house pharmaceutical development capabilities and in-house developed in-vitro diagnostic kit. We are committed to achieve and secure a strategic position in the global market by combining the development of innovative platforms, products and biosimilar products that are in high demand globally. Our vision is to get ourselves established as a trusted and preferred partner in the biopharma space ensuring quality at affordable cost,” concludes Shougandh, Director Quality & Compliance.
.jpg "Overcoming the Hurdles of Scaling a Startup")
